Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting

Jun 10th, 2022Jun 13th, 2022
Vancouver, BC
CA
https://am.snmmi.org/iMIS/SNMMI-AM
The SNMMI 2022 Annual Meeting is recognized as the premier educational, scientific, research, and networking event in nuclear medicine and molecular imaging. The event provides physicians, technologists, pharmacists, laboratory professionals, and scientists with an in-depth view of the latest research and development in the field as well as insights into practical applications for the clinic.
Latest in Home
Breast Imaging Computer Screen Thumbnail
Survey: Nearly 4 out of 5 practices short on breast imagers
February 18, 2026
Prostate Imaging
Pooled evidence: Lu-177 PSMA-617 versus established therapies in mCRPC
February 18, 2026
Cardiac Mri Adobe Samunella
Cardiac MRI-based ML model predicts MACE risk for STEMI patients
February 17, 2026
Emergency Entrance
Low-value x-ray persists in patients with maxillofacial trauma
February 17, 2026
More in Home
Survey: Nearly 4 out of 5 practices short on breast imagers
By Amerigo Allegretto
New survey data by Medicus point to staffing shortages of breast radiologists among U.S. practices.
February 18, 2026
Breast Imaging Computer Screen Thumbnail
Pooled evidence: Lu-177 PSMA-617 versus established therapies in mCRPC
By Will Morton
Lu-177 PSMA-617 has a 36% relative reduction in risk of progression versus standard therapies.
February 18, 2026
Prostate Imaging
Cardiac MRI-based ML model predicts MACE risk for STEMI patients
By Amerigo Allegretto
A machine-learning (ML) model based on cardiac MRI and clinical parameters performed well in a study of STEMI patients.
February 17, 2026
Cardiac Mri Adobe Samunella
Low-value x-ray persists in patients with maxillofacial trauma
By Will Morton
Targeted interventions to reduce low-value imaging may improve diagnostic accuracy.
February 17, 2026
Emergency Entrance
'Quadruple low' PCCT protocol improves lung cancer imaging
By Kate Madden Yee
The findings could translate to better care for patients who require repeated contrast-enhanced imaging.
February 17, 2026
2026 02 17 Quadruple Low Pcct Thumbnail
New benchmark helps monitor cumulative CT radiation dose
By Kate Madden Yee
The findings highlight the need for systematic dose tracking and rigorous justification of imaging.
February 13, 2026
Radiation Logo
Study questions routine use of radiotherapy after bone surgery
By Will Morton
Findings suggest a possible hazard associated with postoperative radiotherapy.
February 13, 2026
2026 02 13 Port Fractures Thumbnail
CEUS outshines color Doppler imaging for indeterminate kidney lesions
By Amerigo Allegretto
CEUS outperformed color Doppler ultrasound in a study focusing on indeterminate kidney lesions.
February 13, 2026
2026 02 12 Wfumb Sertic Ceus Kidney Lesions Thumbnail
Women's Imaging MinnieCast, Episode 2: Risk-based vs. annual mammography screening, part 1
By Amerigo Allegretto
Vilert Loving, MD, from Ochsner Health and the SBI discusses breast cancer screening based on annual mammography versus risk.
February 13, 2026
Minnie Cast Thumbnail (1) 1
Chest x-rays reveal atherosclerosis in patients undergoing amputations
By Will Morton
Lower limb amputation is an increasingly common major complication of advanced peripheral arterial disease and diabetes mellitus.
February 12, 2026
2026 02 12 Chest Ac2 Thumbnail
3D MRI technique helps plan treatment for pediatric heart conditions
By Kate Madden Yee
The method makes "heart muscle and heart valves visible while making blood and surrounding tissues transparent," researchers noted.
February 12, 2026
Cardiac Mri Adobe Samunella
Could AI scoring help with managing DCIS?
By Amerigo Allegretto
An AI model showed associations with recurrence after DCIS surgery and performed comparably to established clinical risk models.
February 11, 2026
Images of a 39-year-old who underwent screening mammography. Right craniocaudal (left) and mediolateral oblique (middle) views from preoperative mammography show suspicious grouped fine pleomorphic calcifications (arrows). After biopsy showed ductal carcinoma of situ (DCIS), patient underwent breast-conserving surgery, yielding final diagnosis of ductal carcinoma in situ (intermediate grade, hormone receptor positive). (Right) Screenshot of an output of a commercial AI tool applied to preoperative mammography. AI detected right breast lesion with score of 95% on both views (concentric colored circles). Present study’s reviewing radiologist deemed AI marking to correspond with site of DCIS.
Page 1 of 202
Next Page